A Phase 3 interventional study of Mediclore and Adept in Gynecologic Disease, sponsored by Yong Sang Song. Status unknown at 1 site in South Korea. Open to female participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2017-01-05.
Sponsored by Yong Sang Song · Phase 3, Interventional, and Prevention
The purpose of this study is to evaluate the efficacy and safety of Mediclore®, as an antiadhesive barrier, which is made of Poloxamer, Gelatin and Chitosan.
158 studies on the registry are indexed under Genital Diseases, Female; 33 are open to participants now.
This study's planned enrollment of 192 is above the median of 80 across 114 interventional studies indexed under Genital Diseases, Female.
Browse Genital Diseases, Female studies →This is the only study on the registry with Yong Sang Song as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
adhesion barrier Mediclore 5cc, to apply medical device fully around surgery area
Device: Mediclore
standard treatment for surgery
adhesion barrier, Adept, to apply medical device fully around surgery area
Device: Adept
apply medical device fully around intrauterine surgery area
Also known as: Poloxamer, Gelatin and Chitosan.
apply medical device fully around intrauterine surgery area
adhesion rate
4 weeks after surgery, finding adhesion using visceral slide test
Time frame: 4 weeks after surgery
Incidence of adhesion symptoms
4 weeks after surgery, Identifying adhesion sysmptoms using Questionnaire
Time frame: 4 weeks after surgery
adverse event
identifying adverse events after surgery
Time frame: 4 weeks after surgery
Plan to share: Undecided
No publications or documents are linked to this record.
This study is status unknown, as verified in Jan 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.